Introduction In a recent judgment dated August 22, 2025, the Madras High Court in Amgen Inc. v. Assistant Controller of Patents 1overturned the Controller’s decision to reject patent Application No. 5857/CHENP/2008 which had been rejected under Sections 3(d), 3(e), 2(1)(ja) (lack of inventive step), and 10(4) of the Patents Act, 1970 for insufficiency of disclosure. […]
Introduction In a recent development for biologics patents in India, the Delhi High Court has granted interim relief to E.R. Squibb in their infringement suit1 against Zydus Lifesciences. The suit concerns IN 340060, which claims the monoclonal antibody Nivolumab—commercially known as Opdivo®—used in immunotherapy for various cancers. On July 18, 2025, the Court restrained Zydus […]